The post ‘Too chaotic to predict’ – Can Bitcoin really survive 2026 volatility? appeared on BitcoinEthereumNews.com. There’s no analyst consensus for the BitcoinThe post ‘Too chaotic to predict’ – Can Bitcoin really survive 2026 volatility? appeared on BitcoinEthereumNews.com. There’s no analyst consensus for the Bitcoin

‘Too chaotic to predict’ – Can Bitcoin really survive 2026 volatility?

For feedback or concerns regarding this content, please contact us at [email protected]

There’s no analyst consensus for the Bitcoin price outlook for 2026. 

In a recent client memo, Fundstrat warned of choppy markets and a potential BTC dip toward the $60K–$65K zone.

Fundstrat’s Crypto Strategy Head Sean Farrell said ETF inflow exhaustion and post-halving miner selling could pressure prices short term.

Source: Fundstrat

This was contrary to the fund’s head of research, Tom Lee’s public call for a new all-time high of $200K by early January, sparking confusion and community backlash

But Fundstrat was not the only bear in early 2026. 

Bitcoin’s mixed 2026 outlook

Galaxy’s head of firmwide research, Alex Thorn, viewed 2026 as “too chaotic to predict.”  He added that a new ATH high was “still possible,” but the uncertainty was high ahead of elections. 

However, Thorn was confident of a $250K by 2027. 

In contrast, Bitwise and Grayscale projected a new ATH in H1 2026, citing demand for safe havens and renewed ETF inflows. 

For Thorn, the structure could reclaim bullish momentum only if BTC surges above $100K-$105K in the mid-term. 

Near-term sideways structure

In the short term, however, analysts noted that the next Bitcoin direction could be set after Christmas Day. About $23 billion in Bitcoin [BTC] options are set to expire on the 26th of December, pointing to a likely volatile year-end. 

According to analyst James Van Straten, top funds have been actively hedging around $85K-$90K and the expiry on the 26th of December will clear this wall (Gamma flush theory). 

Source: X

On the ETF front, last week, investors withdrew nearly $500 million from the products, underscoring the overall risk-off mode during the heavy macro updates. 

However, there has been tepid ETF demand since October, which could further suppress prices at current levels. 

Source: Soso Value


Final Thoughts 

  • Major funds and asset managers are split on BTC projections in 2026.
  • Analysts expect the next near-term direction to be set after December 26.

Next: $1.5B flows into tokenized gold – Are investors abandoning Bitcoin?

Source: https://ambcrypto.com/too-chaotic-to-predict-can-bitcoin-really-survive-2026-volatility/

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$68,028.39
$68,028.39$68,028.39
-0.69%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09